drugset / Trial / NCT02908035
Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a prospective, multi-center, randomized, dose escalation study to document the effects of adventitial delivery of temsirolimus (Torisel) after revascularization of lesions below the knee in symptomatic patients with critical limb ischemia (CLI).
Timeline
- Start
- 2017-03-03
- Primary completion
- 2020-09
- Completion
- 2021-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Temsirolimus | Small molecule | 0.1 mg/ml | Other |
| Comparator | Temsirolimus | Small molecule | 0.4 mg/ml | Other |